IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    'There is no funding for abortion' in AIDS program...It's pro-life,' says senator

    08:56
  • Women harmed by Texas anti-abortion law take fight to state supreme court

    04:26
  • More women denied abortions in Texas join lawsuit against the state 

    06:48
  • 'Periodical' aims to de-stigmatize menstruation and menopause

    02:41
  • Senator identifies 'Insulin Deserts' in new report calling for lower drug costs

    07:30
  • Thundergong benefit concert set to bang into Kansas City

    09:12
  • Successful PEPFAR AIDS program in jeopardy

    02:37
  • 'People were paying attention': Ohio voters overcome GOP obfuscation to enshrine abortion rights

    04:15
  • Republicans resort to lies and deception ahead of vote on popular abortion rights amendment in Ohio

    07:59
  • 'It lasts longer, it starts earlier': Experts explain puberty

    06:46
  • Inside the fight to end period poverty

    04:36
  • How a shutdown could impact health care for veterans

    03:36
  • ‘They’re obsessed’: Dr. Fauci on death threats, 'lab leak,' and vaccine safety

    27:57
  • Melinda French Gates: investing in health systems in impoverished places will bring ‘less conflict’

    06:23
  • Struggles with self-doubt at the heart of 'Unreliable Narrator'

    07:35
  • Growing concerns about hospice fraud

    07:13
  • Preparation for the next pandemic relies on persuasion, says author

    07:24
  • Common over-the-counter decongestant does not work, FDA panel says

    03:16
  • 'Richer, wealthier and happier': The future of AI and its impact on humanity

    06:21
  • WH: The beginning of lowering drug costs for seniors

    05:19

Shkreli's other drug pricing controversy

08:09

One of Martin Shkreli's companies announced plans to submit a treatment for a parasitic ailment known as Chagas disease for FDA approval next year, with plans to hike the price. The treatment can currently be obtained by doctors free through the CDC. Daisy Hernandez from Miami University and Bloomberg's Keri Geiger join to discuss.